Sfoglia per AUTORE
ROSELL R
Collezione AOU San Luigi di Orbassano

  

Items : 8

RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center. in Personalized medicine / Per Med. 2022 Sep;19(5):395-401. doi: 10.2217/pme-2022-0020. Epub 2022 Jul 8.
2022
AOU San Luigi di Orbassano

Luca C; Pepe F; Pisapia P; Iaccarino A; Righi L; Listì A; Russo G; Campione S; Pagni F; Nacchio M; Conticelli F; Russo M; Fabozzi T; Vigliar E; Bellevicine C; Rocco D; Laudati S; Iannaci G; Daniele B; Gridelli C; Cortinovis DL; Novello S; Molina-Vila MA; Rosell R; Troncone G; Malapelle U;

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer. in Cancers / Cancers (Basel). 2021 Jan 4;13(1):139. doi: 10.3390/cancers13010139.
2021
AOU San Luigi di Orbassano

De Luca C; Pepe F; Iaccarino A; Pisapia P; Righi L; Listì A; Greco L; Gragnano G; Campione S; De Dominicis G; Pagni F; Sgariglia R; Nacchio M; Tufano R; Conticelli F; Vigliar E; Bellevicine C; Cortinovis DL; Novello S; Molina-Vila MA; Rosell R; Troncone G; Malapelle U;

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe. in Journal of clinical pathology / J Clin Pathol. 2020 Jul 31:jclinpath-2020-206957. doi: 10.1136/jclinpath-2020-206957.
2020
AOU San Luigi di Orbassano

Malapelle U; Pisapia P; Iaccarino A; Barberis M; Bellevicine C; Brunnström H; de Biase D; De Maglio G; Ericson Lindquist K; Fassan M; Fontanini G; Gruppioni E; Hofman P; Merkelbach-Bruse S; Molina Vila MA; Pujals A; Rapa I; Righi L; Rosell R; Schildgen O; Schildgen V; Schmitt FC; Tallini G; Vander Borght S; Vigliar E; Volante M; Wagener-Ryczek S; Weynand B; Troncone G; et alii...

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification. in Nature biotechnology / Nat Biotechnol. 2018 Dec 17. doi: 10.1038/nbt.4313.
2018
AOU San Luigi di Orbassano

Bulik-Sullivan B; Busby J; Palmer CD; Davis MJ; Murphy T; Clark A; Busby M; Duke F; Yang A; Young L; Ojo NC; Caldwell K; Abhyankar J; Boucher T; Hart MG; Makarov V; Montpreville VT; Mercier O; Chan TA; Scagliotti G; Bironzo P; Novello S; Karachaliou N; Rosell R; Anderson I; Gabrail N; Hrom J; Limvarapuss C; Choquette K; et alii...

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Dec;13(12):1818-1831. doi: 10.1016/j.jtho.2018.09.017. Epub 2018 Sep 27.
2018
AOU San Luigi di Orbassano

Blumenthal GM; Bunn PA Jr; Chaft JE; McCoach CE; Perez EA; Scagliotti GV; Carbone DP; Aerts HJWL; Aisner DL; Bergh J; Berry DA; Jarkowski A; Botwood N; Cross DAE; Diehn M; Drezner NL; Doebele RC; Blakely CM; Eberhardt WEE; Felip E; Gianni L; Keller SP; Leavey PJ; Malik S; Pignatti F; Prowell TM; Redman MW; Rizvi NA; Rosell R; et alii...

ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2012 May;48(7):961-73. doi: 10.1016/j.ejca.2012.02.001. Epub 2012 Mar 6.
2012
AOU San Luigi di Orbassano

Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC;

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6.
2005
AOU San Luigi di Orbassano

Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L;

Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer. in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):32-7.
2004
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Crino L; Rosell R;